Study of Isatuximab and Cemiplimab in Relapsed or Refractory Natural Killer/T-cell Lymphoid Malignancy
Clinical trial NCT04763616 · COMPLETED
Trial details
- NCT number
- NCT04763616
- Sponsor
- Won Seog Kim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2023-04-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.